Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | APP | P05067 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.51 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.51 |
| ▸ | TBXAS1 | P24557 | 13/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | PLOD2 | O00469 | 1/20 | 0.49 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28994933 | 0.91 | TBXAS1 (0.55) | ALDH1A1LMNAKMT2ATDP1TBXAS1 | |
| SCHEMBL17895063 | 0.86 | ALDH1A1 (0.66) | ALDH1A1LMNAKMT2ATDP1TBXAS1 | |
| SCHEMBL9696292 | 0.86 | ALDH1A1 (0.60) | ALDH1A1LMNAKMT2ATDP1APP | |
| SCHEMBL27623813 | 0.86 | ALDH1A1 (0.56) | ALDH1A1LMNAKMT2ATDP1APP | |
| SCHEMBL6762577 | 0.85 | ALDH1A1 (0.51) | ALDH1A1LMNAKMT2ATDP1APP | |
| SCHEMBL4646985 | 0.84 | ALDH1A1 (0.54) | ALDH1A1LMNAKMT2ATDP1APP | |
| SCHEMBL23069546 | 0.84 | L3MBTL1 (0.60) | ALDH1A1LMNAKMT2ATDP1APP | |
| SCHEMBL9696285 | 0.83 | ALDH1A1 (0.66) | ALDH1A1LMNAKMT2ATDP1APP | |
| SCHEMBL4996696 | 0.82 | ALDH1A1 (0.64) | ALDH1A1LMNAKMT2ATDP1APP | |
| SCHEMBL514512 | 0.82 | ALDH1A1 (0.59) | ALDH1A1LMNAKMT2ATDP1APP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11912691-B2 | Tocotrienols derivates, methods and uses thereof | GLOBAL SCIENTIFIC (US) | 2024-02-27 | — | — | US | disclosed |
| US-20230271948-A1 | TOCOTRIENOLS DERIVATES, METHODS AND USES THEREOF | GLOBAL SCIENTIFIC (US) | 2023-08-31 | — | — | US | disclosed |
| EP-4225299-A1 | TOCOTRIENOLS DERIVATES, METHODS AND USES THEREOF | Global Scientific (US) | 2023-08-16 | — | — | EP | disclosed |
| CN-116390713-A | Tocotrienol derivatives, methods and uses thereof | 全球科学公司 | 2023-07-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11912691-B2 | Tocotrienols derivates, methods and uses thereof | NAMPT, NAPRT, NNT | ALDH1A1 849/4885LMNA 891/4885KMT2A 3297/4885 |
| US-20230271948-A1 | TOCOTRIENOLS DERIVATES, METHODS AND USES THEREOF | NAMPT, NAPRT, NNT | ALDH1A1 849/4885LMNA 891/4885KMT2A 3297/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.